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Immunologists have found it difficult to reach a concensus on the mediators of the 
activity of helper  T  cells.  Both  antigen-specific  and  nonspecific  factors  have  been 
reported  (1-7),  which  we  have suggested  operate  at  different  stages  in  the  B  cell 
response (8-10).  Most preparations of nonspecific factors have been produced under 
conditions  of polyclonal  T  cell  stimulation,  most  often  using  the  T  cell  mitogen 
concanavalin A  (Con A). 1 The production of active supernates from normal T  ceils 
generally  requires  the  presence  of Ia  +  adherent  cells  (11),  therefore,  the  resultant 
supernates  contain  a  variety of T  cell  and  non-T cell  products,  which  potentially 
could both stimulate and suppress the B cell response. The picture has been further 
complicated by the recent findings of Watson et al. (12-14), who have demonstrated 
that  a  major  component  of nonspecific  T  cell  supernates  is  T  cell  growth  factor 
(TCGF) or interleukin-2  (IL2), whose activity in helper assays they suggest is caused 
by its ability to stimulate the activity of the small number of T  cells present in B cell 
preparations, rather than caused by its direct effect on B cells. 
As part of our effort to sort out the number and mechanism of action of helper T 
cell mediators we have been attempting to produce T  cell hybridomas, which secrete 
one or at least only a  few different mediators. We report here the successful isolation 
of a  cloned stable T  cell hybridoma, FS6-14.13, which when stimulated with Con A 
produces a  factor indistinguishable from IL2. Moreover, other helper factors present 
in  the  Con  A-stimulated  supernate  of normal  spleen  cells  (normal  Con  ASn)  are 
missing in  the  hybridoma Con  ASn.  This conclusion  was  reached  in  experiments 
demonstrating that unlike normal Con ASn, the hybridoma Con ASn was dependent 
on both T  cells an adherent cells in order to be active in stimulating B cell responses 
to the antigen sheep red blood cells (SRBC). 
Materials and Methods 
Mice.  B6D2FI  mice  were  either  purchased  from  The Jackson  Laboratory,  Bar  Harbor, 
Maine, or bred in our own facilities. 
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Antigens and Mitogens and  Other Reagents.  SRBC  from  a  single animal  (number 220)  were 
purchased  from  the Colorado Serum  Co.,  Denver,  Colo.  Ovalbumin  (OVA)  and  a-methyl 
mannoside  (a-MM)  were  obtained  from  Sigma  Chemical  Co.,  St.  Louis,  Mo.  Con  A  was 
obtained  from  Miles-Yeda  Ltd.,  Elkhart,  Ind.  Hypoxanthine  (H),  aminopterin  (A),  and 
thymidine (T) were also obtained from Sigma Chemical Co. They were used in culture at a 
final concentration of 1 ×  10  -4 M, 4 ×  10 -7 M, and  1.6 X  10  -5 M, respectively. Polyethylene 
glycol 1540 was obtained from theJ. T. Baker Chemical Co., Phillipsburg, N. J. It was used for 
cell fusion at a concentration of 50% w/w in serum-free medium. 
Cell Culture.  All cells were cultured by modifications (15,  16) of the methods of Mishell and 
Dutton (17), except where noted. 
Cell Preparations.  Treatment with anti-T cell serum and complement (C), nylon fiber column 
isolation of T  cells, and adherent cell depletion using Sephadex G-10 were all performed as 
previously described (3,  16, 18). 
Production of Supernates.  Normal Con ASn was prepared as previously described (3). Briefly, 
B6D2FI spleen cells were cultured at 107/ml overnight in medium containing a 4 ~g Con A/ml. 
Hybridoma and BW5147 tumor cell Con ASn was prepared by culturing the cells at  106/ml 
overnight in medium containing 4 ~g Con A/ml. Cells were removed by centrifugation, and all 
supernates were stored at -20°C until ready for use. 
Antisera.  Rabbit anti-mouse thymocyte serum (ATS) was purchased from Microbiological 
Associates, Walkersville, Md. In vivo, 0.4 ml of a  1:10 dilution was injected intraperitoneally 2 
d  before sacrifice. For use with rabbit or guinea pig C  as a  specific anti-T cell reagent this 
antiserum was absorbed with the B cell tumor lines CH-1 or XS63 as previously described (18). 
CH-1  was  kindly given  to us by Dr.  Noel Warner, Albuquerque,  N.  Mex. AKR  anti-C3H 
(anti-Thy 1.2) was prepared as previously described (19). The batch used in these experiments 
had  been  well  characterized.  When  used  with  selected rabbit  C,  it  killed the  appropriate 
proportions of spleen, lymph node, and thymus cells. It had also been demonstrated to deplete 
Con A responsiveness and helper function without affecting lipopolysaccharide responsiveness 
or B cell function. 
Plaque-forming Cell Assays.  B cells cultured in conventional 0.5-ml cultures were assayed for 
anti-SRBC plaque-forming cells (PFC) by the slide modification of the hemolytic plaque assay 
(17, 20).  B cells cultured in 0. l-ml microcultures were assayed in situ for anti-SRBC PFC (15). 
Results 
Production and Characterization  of FS6-14.13.  Normal B6D2Fx T  cells were fused with 
azaguanine-resistant BW5147  AKR  tumor cells (obtained from the Salk Cell Distri- 
bution Center, La Jolla, Calif.), essentially by the methods of Kontiainen et al.  (21). 
Briefly,  107  T  cells and  108  tumor cells were  fused  for 2  min  in  1 ml  of serum-free 
medium containing 50% w/w polyethylene glycol. The mixture was then diluted over 
a  period of 10 min to a  volume of 50 ml and then incubated for an additional 10 min 
at 37°C. The agglutinated cell suspension was centrifuged and the pellet dispersed in 
medium containing 5% fetal calf serum and  10% nutrient cocktail (complete medium) 
(17). The cells were distributed in 92 wells of 24-well Linbro 76-033-05  tissue culture 
plates.  After  24  h  all  wells  were  supplemented  with  HAT.  Culture  medium  was 
partially replaced several times a  week with HAT containing fresh medium. After 2- 
3 wk stable hybrid growth was seen in 23 wells. These were subcultured into medium 
containing  HT  only  for  several  passages  and  then  finally  into  unsupplemented 
complete medium.  At  this  point  approximately  1.5  ×  106  cells from  each  of these 
cultures (FS6-1 to -23) were incubated overnight in  1.5 ml of culture medium with 4 
#g  Con  A/ml  and  the  adherent  portion of 2  ×  105  peritoneal cells (macrophages). 
The supernates of these cultures were tested for helper factors. 50 ~1 of each supernate 
was added to a set of 12 microcultures containing 2 x  105 T  cell-depleted B cells in 50 
~1  of culture  medium  containing  SRBC  as  antigen.  After 4  d  microcultures  were L.  HARWELL,  B.  SKIDMORE,  P.  MARRACK,  AND J.  KAPPLER  895 
assayed m  situ  for anti-SRBC PFC. Negative control supernates were Con A-supple- 
mented medium and supernate from  macrophage cultures stimulated with Con A. 
The positive control supernate (Sn) was normal Con A  Sn. The results are shown in 
Fig.  I. Only one of the hybrid Sn had any activity (FS6-14). This line was cloned at 
limiting dilution. The resultant clones were tested for factor production as above, and 
all were positive. One clone (FS6-14.13) was selected for further study. FS6-14.13 was 
established as a  T  cell hybrid by the presence of the Thy  1.2  antigen on its surface 
(Fig. 2). 
We established the conditions necessary for the production of an active Sn from the 
hybridoma. Although as a  precaution we originally used macrophages in the produc- 
tion of Sn, we  found that  they were not required and omitted them in subsequent 
experiments. Fig. 3 shows the results of an experiment in which various Sn were tested 
for helper activity. Incubation of the hybridoma cells with Con A produced an active 
Sn. Sn from the hybridoma produced without Con A were without activity. Likewise, 
medium containing Con A, Sn from BW5147 stimulated with Con A, and Sn from 
unstimulated  FS6-14.13 to which Con A was added after the removal of the hybridoma 
cells were all inactive. 
There  are  several  points concerning the  response of FS6-14.13  to  Con  A  worth 
noting. These are demonstrated by the data presented in Fig. 4. After the addition of 
Con A  no helper activity was present in the Sn until at least 4 h. No further increase 
in activity was seen after about 24 h. In this respect the hybridoma behaved similarly 
to normal T  cells. However, unlike the ease with the majority of normal T  cells, the 
growth of the hybridoma was severely inhibited by the presence of Con A. That this 
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FIG.  I.  Isolation of T cell hybridoma, FS6-14.13. Hybrids between B6D2FI T cells and BW5147 
tumors cells were prepared as described in the text. Con ASn were prepared with cells from the 23 
culture wells that were positive for growth by culturing approximately 1.5 ×  l06 cells in 1.5 ml of 
culture medium containing 4 #g/ml Con A and the adherent portion of 2 ×  l0  ~ peritoneal cells. 
The Con ASn were tested for helper activity as follows: for each supernate (Sn) a set of 12 
microcuhure wells was prepared containing 50/.d complete medium, 50 /~1 Sn, 2 ×  l0  s T  cell- 
depleted spleen cells prepared from ATS-treated mice (17), and SRBC as antigen. After 4 d each 
microculture was assayed in situ  for anti-SRBC  PFC. The results are shown as  the  total  PFC 
observed in a set of 12 identical wells. Negative control preparations were Con A-supplemented 
complete medium and a Sn from cultures containing Con A and macrophages only. The positive 
control Sn was normal Con ASn. Only one of the hybrid Sn had any activity (from FS6-14). This 
line was cloned at limiting dilution and one of the clones (FS6-14.13) used in subsequent experiments. 896  I NTERLEUKIN-2-PRODU(21NG  HYBRIDOMA 
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Ftc.  2.  Presence  of Thy  [.2 on FS6-14.13. The cytotoxic titer of anti-Thy 1.2 (AKR anti-C3H) 
either before (O)  or  after  (0)  absorption with  B6D2FI thymocytes was determined on normal 
B6D2FI thymocytes (a), FS6-14.13 (b), and BW5147 (c) as previously described (22), except that 
heat-inactivated fetal calf serum, rather than guinea pig serum was used as the dilutent  for  the 
rabbit (2, which was used at a  final concentration of 1:80.  Results are shown as actual percent dead 
without correction for cell death with (2 alone. 
IO,  OOO 
1,000 
=; 
k- 
a.  tO0 
~<lO 
Normal Spleen  / 
Con A Sn 
5  IO  20  40  80 
SUPERNATE CONCENTRATION  (%) 
FIe.  3.  Requirement for Con A stimulation in the production of helper factor by FS6-14.13. ASn 
was prepared  from FS6-14.13 cultured overnight at  106/ml in complete medium containing 4 #g 
Con A/ml (0). Other preparations (×) were Sn from BW5147 cultured with or without Con A, Sn 
from  FS6-14.13  cultured  without  Con A,  Sn  from  FS6-14.13  cultured without  Con  A  and then 
supplemented with Con A after the removal of the cells, and complete medium supplemented with 
Con  A.  The  positive  control  Sn  (C)) was  normal  (]on  ASn.  Various  concentrations  of each 
preparation  were added to triplicate culture wells (Linbro  76-033-05) containing 2  ×  106 T  cell- 
depleted B6D2FI spleen cells from ATS-treated mice and SRBC as antigen in a  total volume of 0.5 
ml. After 4 d  identical culture wells were pooled and assayed for anti-SRBC PFC. L.  HARWELL, B.  SKIDMORE, P.  MARRACK, AND J.  KAPPLER 
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FIG.  4.  Kinetics of factor production  and effect of Con A on the growth of FS6-14.13. (a)  Sn 
prepared from FS6-14,13 at various times after stimulation with Con A were tested at a concentration 
of 60% in microcuhure's as in Fig. 1. The results are shown as the total number of anti-SRBC PFC 
in  12 identical microculture wells vs. the time of the harvest of the Sn. In (b) FS6-14.13 cells were 
plated at 104/ml in complete medium with (0) or without (O) 4/xg  Con A/ml. The cell concentration 
was determined at  various times after the initiation of the culture.  (c) represents similar growth 
curves for BW5147 cells. 
897 
property of the hybridoma was contributed by the normal parent  was shown by the 
lack of effect of Con A  on the growth of the parental  tumor cell line BW5147. 
Production of IL2 by FS6-14.13.  Because the experiments  of Watson et  al.  (12-14) 
had  shown  that  a  major helper  factor in  normal  Con A  SN was TCGF  or IL2, we 
tested  FS6-14.13 Con A  SN for the presence of this  activity assayed by its ability to 
maintain  the proliferation of antigen-specific activated T  cell blasts. 
OVA-specific  T  cell  blasts  were  produced  as  previously  described  (23).  Briefly, 
OVA-primed lymph node T  cells were cultured with OVA for 4  d. The T  cell blasts 
were isolated and their growth continued for an additional  4 d  in normal Con ASn. 
Previous experiments  had  shown  that  at  this  point  the  blasts  would  continue  their 
growth only in cultures containing either Con ASn  or OVA with irradiated  splenic 
filler cells (23). Various preparations were tested for their ability to support the growth 
of these blasts.  The results are shown in Fig.  5. Growth stopped abruptly  in normal 
culture  medium  or  in  BW5147  Con  ASn.  Vigorous  growth  was  seen  in  cultures 
containing normal or FS6-14.13 Con ASn. Other experiments have shown FS6-14.13 
Con ASn  to be as effective as normal Con ASn  in supporting the growth of Con A- 
activated T  cell blasts and two long-term helper T  cell lines, HT-1 and HT-2 (kindly 
provided  by  Dr. James  Watson,  University  of California,  Irvine,  Calif.)  (data  not 
shown).  In addition,  the  presence of IL2 activity in  FS6-14.13  Con A  SN has been 
independently confirmed by Dr. Steven Gillis, Seattle, Wash. and Dr. Thomas Hiinig, 
Massachusetts  Institute  of Technology, Cambridge,  Mass.  (S.  Gillis  and  T.  HiJnig. 
Personal communications.). 
Thus,  it  appeared  that  FS6-14.13  produced  a  IL2-1ike activity  when  stimulated 
with  Con  A.  This  conclusion  was  supported  by  the  results  of  Sephadex  G-200 
chromatography.  Samples of both normal and hybridoma Con ASn  were analyzed. 
The effluent fractions were assayed in both B cell and T  cell stimulation  assays. The 898  INTERLEUKIN-2-PRODUCING  HYBRIDOMA 
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F'IG.  5.  Presence of [L2 activity in FS6-14.13 Con ASn. OVA-specific T  cell blasts were prepared 
as  previously  described  (22).  Microcuhures  were  prepared  containing  various  concentrations  of 
either FS6-14.13 Con ASn  (O), BW5147 Con A Sn (×), or either of two batches of normal Con A 
Sn (©,/~)  (all supplemented  with 20 rag/m[ a-MM)  and  104 OVA-speclfic T  cell blasts. The cells 
were cultured  for 4 d. During the last  24 h  of culture,  1 ~Ci of [SH]thymidine  (sp act 6,700 #Ci/ 
#tool)  was added  to  each  culture.  The  incorporated  nH  was determined  by  liquid  scintillation 
counting of the cells. Each point represents the average incorporated radioactivity in three replicate 
cultures. Similar results were obtained in numerous other experiments. 
results  are  shown  in  Fig.  6.  Although  the  total  recovery  of  the  T  cell  growth- 
stimulating activity was somewhat less than that of the B cell helper activity, for both 
Sn the activity in each assay emerged from the column shortly after albumin  in the 
30-40,000  mol wt range, consistent with results previously reported by this and other 
laboratories (3, 4,  12,  13,  24). There was a slight  tendency with FS6-14.13  Con A  Sn 
for the activity  in  the B  cell  assay to emerge before the activity  in  the T  cell  assay. 
Whether this difference represents heterogeneity in the factors in this Sn will have to 
be decided with more discriminating fractionation techniques. 
Presence of Additional  Helper Factors in Normal Con ASn.  The results presented in the 
previous section indicated that IL2 was a  major component of FS6-14.13  Con A  Sn. 
The question remained whether additional  factors such as those previously reported 
to be present in normal Con A  Sn were also present  in the hybridoma preparations. 
The results of the experiments presented in Figs.  1, 2, 4, 5 already suggested a possible 
deficiency  in the FS6-14.13  Con A  Sn in that although this preparation was consist- 
ently stronger than normal Con A Sn in tests ofT cell growth, it was weaker in assays 
for  helper  activity  for  B  cells.  We  performed  two  additional  experiments  both  of 
which  indicated  that  IL2  was  the  only  or  at  least  the  major  helper  factor  in  the 
hybridoma Sn, but that additional factors were present in normal Con A  Sn. 
In the first  experiment  we tested  the prediction  that  the activity of IL2  in B  cell 
responses  was  dependent  on  its  stimulation  of  T  cells  contaminating  the  B  cell L.  HARWELL,  B.  SKIDMORE,  P.  MARRACK, AND J.  KAPPLER 
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FtG. 6.  Sephadex (3-200 chromatography of FS6-14.13  and normal Con ASn. A  100- ×  2.5-cm 
Sephadex G-200 column was  prepared and equilibrated with 0.1  M  (NH4)HCO3.  On sequential 
runs 7 ml of either FS6-14.13 or normal Con ASn was applied to the column and eluted with 0.1 
M  (NH4)HCO3.  16-ml fractions were taken and thoroughly lyophilized removing both  H20 and 
(NH4)HCOa.  The residues  were resuspended  in 4 ml of complete culture medium and tested  for 
activity in both the response of T cell-depleted B cells to SRBC (~) and the stimulation of growth 
in OVA-specific T cell blasts  (×--×). In the anti-SRBC response the fractions  were tested  at 80% 
in microcultures prepared and assayed  as in Fig.  1. The recovered activity from the column was 
approximately 75% for the FS6-14.13 Con A Sn and approximately 100% for the normal Con ASn. 
In the test with OVA-specific T cell blasts, the fractions were supplemented with 20 mg/ml a-MM 
and tested at 50% as in Fig. 5. The recovered activity from the column was approximately 10-20% 
for the FS6-14.13  Con ASn and  approximately 30-50%  for the normal Con ASn. The protein 
concentrations of the eluates are shown  (--) determined by ahsorbancy at approximately 280 nm 
with  a  bovine serum  albumin  (BSA) standard.  The absorbancy  in  fractions  25-35  was  caused 
primarily by phenol red and other low molecular weight compounds in the culture medium. The 
molecular weight scale was determined with the following markers:  ferretin,  IgG, BSA, chymotryp- 
sinogen A, and cytochrome c, 
preparation,  but  that  normal  Con  ASn  contained  additional  factors  that  could 
stimulate  the  B  cell  response  in  the  absence  of  T  cells.  A  number  of  previous 
observations  led to the design of this experiment. 
We  (18)  and  others  (25),  had  shown  that  treatment  of normal  spleen  cells with 
anti-T  cell serum  and  C  did  not  fully abolish  helper T  cell activity.  Although  cells 
prepared  in  this  manner  did  not  respond  to  SRBC,  they  contained  enough  T  cells 
such  that  a  good anti-SRBC  response  was obtained  by the addition  of Con  A  to the 
cultures. We demonstrated  (18)  that  the bulk of these contaminating  T  cells could be 
removed by pretreatment  of the spleen cell donor with ATS in vivo before the in vitro 
treatment  with anti-T cell serum and C. Such preparations  failed to respond  to SRBC 900  INTERLEUK1N-2-PRODUCING HYBRIDOMA 
even when Con A was added to the cultures. A further important observation was the 
finding that the activity of IL2 in stimulating T  cells was dependent on their previous 
activation with either antigen or mitogen. IL2 was shown to be inactive on resting T 
cells (26). 
Therefore, we designed an experiment in which  normal and FS6-14.13  Con ASn 
were compared in their helper activity under conditions where responsiveness to IL2, 
but  not  to  factors  directly  reactive with  B  cells,  should  be selectively diminished. 
Namely, after reduction  in the number of T  cells by earlier treatment of the B  cell 
donors with ATS, and/or after reduction in the activation ofT cells by Con A present 
in the Sn  (and consequently their susceptibility to IL2) by addition of a-MM to the 
culture. 
As shown in Fig.  7, normal spleen cells treated with anti-T cell serum and C  failed 
to  respond  to  SRBC,  but  mounted  a  respectable  response  with  the  addition  of 
mitogenic  amounts  of Con  A  (a).  The  efficacy  of the  methods  to  reduce  T  cell 
stimulation described above is demonstrated by the elimination of this ability of Con 
A  to induce a  response either by the pretreatment of the B cell donors with ATS (b) 
or by the addition  of a-MM  to the culture  (c). Using cells treated with only anti-T 
cell  serum  plus  C  in  vitro  FS6-14.13  and  normal  Con  ASn  produced  equivalent 
responses. However, although either the addition of a-MM or pretreatment of the B 
cell donors with ATS dramatically reduced the response obtained in the presence of 
the hybridoma Sn, these procedures had a  much less dramatic effect on the activity 
of the normal Con ASn (b and c). Most importantly, the combination of ATS in vivo 
and a-MM in culture virtually eliminated the activity of the hybridoma Sn, whereas 
this combination had much less effect on the activity of normal Con ASn  (d). 
We interpret these findings as an indication that the activity of FS6-14.13  Con Sn 
in B cell responses was dependent on the presence and activation ofT cells, a property 
consistent with its containing IL2 as its primary, if not only, activity. Normal Con A 
Sn, on the other hand, clearly was sufficient for a  response even under conditions of 
extremely low T  cell activity, which suggests the presence of additional factors. 
A  second experiment supporting these conclusions stemmed from the observation 
by Hoffmann and Watson (27)  that purified IL2 was ineffective in B cell responses in 
the  absence  of adherent  cells.  Because  we  had  previously  demonstrated  that  the 
activity of normal Con A  Sn was not dependent on adherent ceils (3), we compared 
the hybridoma and normal Sn for their activities in adherent cell depleted cultures. 
The  results  are  shown  in  Fig.  8.  Anti-T  serum  plus  C-treated  normal  spleen  cells 
responded equally well to both Sn as demonstrated above. Passage of the cells over 
Sepadex G-10 to remove adherent  cells had no effect on the activity of the  normal 
Con A Sn, as we previously reported. The procedure, however, totally eliminated the 
response obtained with the hybridoma Sn. This result was again consistent with IL2 
being the predominant activity in the hybridoma Sn and again indicated the presence 
of additional activities in the normal Con ASn. 
Discussion 
The cloned T  cell hybridoma, FS6-14.13,  clearly responded to Con A  stimulation 
with the production of an activity thus far indistinguishable from TCGF or IL2. This 
factor could be assayed by its ability to stimulate the growth of activated T  cells or to 
restore the response of partially T  cell-depleted B cells to the antigen, SRBC. L.  HARWELL,  B.  SKIDMORE,  P.  MARRACK,  AND J.  KAPPLER 
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FIo.  7.  Effect ofthorough T  cell depletion and Con A inhibition on the activity of FS6-14.13 and 
normal Con ASn. T  cell-depleted B cells were prepared  by treatment of spleen cells from either 
normal (a and c) or ATS-pretreated (b and d) mice with anti-T cell serum and C. These cells were 
cultured at 1.5 X  105/microeuhure with SRBC as antigen. Cultures were supplemented with various 
concentrations of either medium containing 4 #g/ml Con A (X), FS6-14.13 Con ASn (O), or normal 
Con ASn (O). In addition, half the cultures (c and d) received 20 mg/ml 0t-MM+ Results are shown 
as the total anti-SRBC PFC  in a  set of 12 identical  microcultures on day 4.  Similar results were 
obtained in two additional experiments. 
The results reported here,suggest that IL2 may be the only active principle present 
in the hybridoma Sn. Thorough T cell depletion of B cell preparations in combination 
with the prevention of T  cell activation by Con A with a-MM eliminated the ability 
of the hybridoma to induce a B cell response. These procedures did not eliminate the 902  INTERLEUK|N-2-PRODUCING HYBR|DOMA 
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FIG.  8.  Effect  of adherent  cell  depletion  on  the  activities  of FS6-14.13  and  normal Con  ASn. 
Spleen cells  from normal  mice were either  left  unseparated  (a)  or depleted  of adherent  cells  by 
passage over a  Sephadex G-10 column (b). Both preparations were treated with anti-T cell  serum 
and C. These cells were cultured as in Fig.  7 with various concentrations of either FS6-14.13  (0) or 
normal (Q)) Con ASn with SRBC as antigen.  Results are presented as the total anti-SRBC  PFC 
present in a set of 12 identical microcuhures on day 4. Similar results were obtained in an additional 
experiment. 
activity of normal Con ASn, thus indicating the presence of activities in the normal 
Sn which were absent in the hybridoma Sn. 
Depletion of adherent cells from the B cell preparation also eliminated the activity 
of the hybridoma Sn, without  effecting the activity of normal Con  ASn.  Whether 
this is an indication of essential helper factors produced by adherent cells as suggested 
by Hoffman and Watson (27)  or whether this indicates the involvement of adherent 
cells in T  cell activation is not distinguished by the results. However, this finding does 
support the IL2 nature of the active principle in the hybridoma Sn and offers further 
support for the conclusion that normal Con A Sn contains factors in addition to IL2. 
Although our results indicate that IL2 is not sufficient for a  B cell response in the 
absence of T  cells, they do not show that IL2 is without effect on B cells. Results of 
experiments performed in  collaboration  with  Dr.  David  Parker,  Worchester,  Mass. 
(28),  indicated  that  even  in  the  absence  of T  cells,  the  hybridoma  Con  ASn 
dramatically stimulated the proliferation without antibody secretion of polyclonally 
activated B cells. Whether this represents the activity of IL2 or a second factor in the 
hybridoma Sn will have to be decided in future experiments. 
The finding that normal Con ASn  contained helper activities in addition  to IL2 
supported the conclusions of a  number of laboratories, who have reported multiple 
types of nonspecific helper  factors  (13,  24,  27).  FS6-14.13  should  prove useful  as a 
source of one of these factors uncontaminated by the others. In addition this cell line 
represents a  useful resource for the large scale production of IL2 for the continuous 
culture of T  cell lines. 
Summary 
The fusion of an AKR T  cell tumor line to normal B6D2Fx, T  cells resulted in the 
production  of a  cloned  T  cell  hybridoma  (FS6-14.13)  inducible  with  the  mitogen L.  HARWELL, B. SKIDMORE,  P.  MARRACK, AND J. KAPPLER  903 
concanavalin A  (Con A). The supernate from Con A-stimulated hybridoma cells was 
active both in the stimulation of an anti-sheep red blood cell response by partially T 
cell-depleted  B  cells and  in the stimulation  of the growth of antigen-specific T  cell 
blasts. The active principle in both assays had a  molecular weight of approximately 
30-40,000. These results indicated the presence of interleukin 2 (IL2) in the hybridoma 
supernate. 
The activity of the hybridoma supemate in B cell responses was dependent on the 
presence of adherent cells and a  few contaminating T  cells. On the other hand, Con 
A-stimulated supernates  from normal  spleen  cells were active after either adherent 
cell removal or severe T  cell depletion. These results suggested that IL2 was the only 
active helper factor in  the hybridoma supernate,  but  that  additional  helper factors 
were present in supernates from Con A-stimulated normal spleen cells. 
We thank Jan Moynihan, James Leibson, Ella Kushnir, and Janice White  for their expert 
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